Literature DB >> 11722269

Death due to bioterrorism-related inhalational anthrax: report of 2 patients.

L Borio1, D Frank, V Mani, C Chiriboga, M Pollanen, M Ripple, S Ali, C DiAngelo, J Lee, J Arden, J Titus, D Fowler, T O'Toole, H Masur, J Bartlett, T Inglesby.   

Abstract

On October 9, 2001, a letter containing anthrax spores was mailed from New Jersey to Washington, DC. The letter was processed at a major postal facility in Washington, DC, and opened in the Senate's Hart Office Building on October 15. Between October 19 and October 26, there were 5 cases of inhalational anthrax among postal workers who were employed at that major facility or who handled bulk mail originating from that facility. The cases of 2 postal workers who died of inhalational anthrax are reported here. Both patients had nonspecific prodromal illnesses. One patient developed predominantly gastrointestinal symptoms, including nausea, vomiting, and abdominal pain. The other patient had a "flulike" illness associated with myalgias and malaise. Both patients ultimately developed dyspnea, retrosternal chest pressure, and respiratory failure requiring mechanical ventilation. Leukocytosis and hemoconcentration were noted in both cases prior to death. Both patients had evidence of mediastinitis and extensive pulmonary infiltrates late in their course of illness. The durations of illness were 7 days and 5 days from onset of symptoms to death; both patients died within 24 hours of hospitalization. Without a clinician's high index of suspicion, the diagnosis of inhalational anthrax is difficult during nonspecific prodromal illness. Clinicians have an urgent need for prompt communication of vital epidemiologic information that could focus their diagnostic evaluation. Rapid diagnostic assays to distinguish more common infectious processes from agents of bioterrorism also could improve management strategies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11722269     DOI: 10.1001/jama.286.20.2554

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  47 in total

1.  Inhalational anthrax: radiologic and pathologic findings in two cases.

Authors:  Bradford J Wood; Bryan DeFranco; Mary Ripple; Martin Topiel; Carlos Chiriboga; Venkat Mani; Kevin Barry; Dave Fowler; Henry Masur; Luciana Borio
Journal:  AJR Am J Roentgenol       Date:  2003-10       Impact factor: 3.959

2.  The primary care differential diagnosis of inhalational anthrax.

Authors:  Jonathan L Temte; Andrew R Zinkel
Journal:  Ann Fam Med       Date:  2004 Sep-Oct       Impact factor: 5.166

3.  5-(Dimethoxymethyl)-2'-deoxyuridine: a novel gem diether nucleoside with anti-orthopoxvirus activity.

Authors:  Xuesen Fan; Xinying Zhang; Longhu Zhou; Kathy A Keith; Earl R Kern; Paul F Torrence
Journal:  J Med Chem       Date:  2006-06-01       Impact factor: 7.446

4.  Sepsis and pathophysiology of anthrax in a nonhuman primate model.

Authors:  Deborah J Stearns-Kurosawa; Florea Lupu; Fletcher B Taylor; Gary Kinasewitz; Shinichiro Kurosawa
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

5.  How to optimise the yield of forensic and clinical post-mortem microbiology with an adequate sampling: a proposal for standardisation.

Authors:  A Fernández-Rodríguez; M C Cohen; J Lucena; W Van de Voorde; A Angelini; N Ziyade; V Saegeman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-14       Impact factor: 3.267

Review 6.  Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines.

Authors:  Andrew J Phipps; Christopher Premanandan; Roy E Barnewall; Michael D Lairmore
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

Review 7.  Bioterrorism: a laboratory who does it?

Authors:  David W Craft; Philip A Lee; Marie-Claire Rowlinson
Journal:  J Clin Microbiol       Date:  2014-03-19       Impact factor: 5.948

8.  The physiologic responses of Dutch belted rabbits infected with inhalational anthrax.

Authors:  William S Lawrence; Jason M Hardcastle; Douglas L Brining; Lori E Weaver; Cindy Ponce; Elbert B Whorton; Johnny W Peterson
Journal:  Comp Med       Date:  2009-06       Impact factor: 0.982

9.  Gamma-phage lysin PlyG sequence-based synthetic peptides coupled with Qdot-nanocrystals are useful for developing detection methods for Bacillus anthracis by using its surrogates, B. anthracis-Sterne and B. cereus-4342.

Authors:  Shilpakala Sainathrao; Ketha V Krishna Mohan; Chintamani Atreya
Journal:  BMC Biotechnol       Date:  2009-07-22       Impact factor: 2.563

10.  Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response.

Authors:  Vincent P Hsu; Susan L Lukacs; Thomas Handzel; James Hayslett; Scott Harper; Thomas Hales; Vera A Semenova; Sandra Romero-Steiner; Cheryl Elie; Conrad P Quinn; Rima Khabbaz; Ali S Khan; Gregory Martin; John Eisold; Anne Schuchat; Rana A Hajjeh
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.